COVID-19 pandemic
South Africa suspends its rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
Sources: Sky News
Changes
- South Africa suspends the rollout of Oxford-AstraZenenca's vaccine after the research finds it was less effective against a 501.V2 variant discovered in the country.
- South Africa suspends their rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
- South Africa suspends its rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
Related
President Andrés Manuel López Obrador receives his first dose of the Oxford–AstraZeneca vaccine.